Loading clinical trials...
Loading clinical trials...
This is a prospective, multi-cohort, single-arm Phase II clinical trial evaluating the efficacy and safety of befotertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in patients with ad...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators
NCT06253871 · HER2 Mutation-Related Tumors, HER2, and more
NCT07354061 · NSCLC (Non-small Cell Lung Cancer)
NCT04585750 · Advanced Solid Tumor, Advanced Malignant Neoplasm, and more
NCT05520099 · Immunotherapy, Cancer, and more
NCT07106827 · HCC - Hepatocellular Carcinoma, Cholangiocarcinoma, and more
2nd Affiliated Hospital, School of Medicine
Hangzhou, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions